MedTrace Logo

Faecal Microbiota Transplantation in Irritable Bowel Syndrome

NCT02423421 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-04-22

No results posted yet for this study

Summary

The purpose of thus study is to determine if faecal microbiota transplantation will result in improvement in clinical outcomes in patients with irritable bowel syndrome.

Conditions

  • Irritable Bowel Syndrome

Interventions

OTHER

Faecal microbiota transplantation

Human Stool.

Sponsors & Collaborators

  • University College Cork

    lead OTHER

Principal Investigators

  • Fergus Shanahan, MD, DSc · Professor and Chair Dept. of Medicine, University College Cork

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02423421 on ClinicalTrials.gov